Jane Street Group, LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$25.68 - $35.59 $1.03 Million - $1.43 Million	-40,100 Reduced 31.88%	85,700 $2.97 Million
Q4 2021 Feb 15, 2022	BUY	$24.9 - $40.26 $1.69 Million - $2.73 Million	67,800 Added 116.9%	125,800 $3.68 Million
Q3 2021 Nov 16, 2021	SELL	$25.48 - $37.34 $163,072 - $238,976	-6,400 Reduced 9.94%	58,000 $1.48 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $506,376 - $677,352	15,600 Added 31.97%	64,400 $2.26 Million
Q1 2021 May 18, 2021	SELL	$38.94 - $50.85 $693,132 - $905,130	-17,800 Reduced 26.73%	48,800 $1.99 Million
Q4 2020 Feb 17, 2021	BUY	$37.65 - $63.77 $1.27 Million - $2.15 Million	33,700 Added 102.43%	66,600 $2.88 Million
Q3 2020 Nov 17, 2020	SELL	$52.76 - $74.49 $1.18 Million - $1.66 Million	-22,300 Reduced 40.4%	32,900 $1.81 Million
Q2 2020 Aug 17, 2020	BUY	$48.73 - $81.82 $175,428 - $294,552	3,600 Added 6.98%	55,200 $3.49 Million
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $2.9 Million - $6.07 Million	-69,600 Reduced 57.43%	51,600 $2.64 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $4.41 Million - $7.91 Million	96,600 Added 392.68%	121,200 $9.63 Million
Q2 2019 Aug 15, 2019	BUY	$52.6 - $63.29 $694,320 - $835,428	13,200 Added 115.79%	24,600 $1.29 Million
Q4 2018 Feb 15, 2019	BUY	$31.54 - $46.67 $110,390 - $163,345	3,500 Added 44.3%	11,400 $468,000
Q2 2018 Aug 15, 2018	SELL	$38.7 - $50.15 $27,090 - $35,105	-700 Reduced 8.14%	7,900 $357,000
Q4 2017 Feb 15, 2018	BUY	$29.7 - $45.7 $255,420 - $393,020	8,600	8,600 $338,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.